Ambroxol Shifts Enzyme Markers but Shows No Proven Benefit in Gaucher or GBA1 Parkinson’s
TL;DR: Ambroxol, an old cough medicine, can boost a key brain enzyme in lab studies, but a review of 20 clinical reports found no proven benefit in Gaucher disease or GBA1-linked Parkinson’s. In a randomized trial of people with GBA1-linked Parkinson’s, ambroxol did not improve thinking-test scores over 1 year; scores slightly favored placebo. Key …
